Recurrent COLQ mutation in congenital myasthenic syndrome.
Alev Guven, Mehmet Demirci, Banu Anlar
Index: Pediatr. Neurol. 46(4) , 253-6, (2012)
Full Text: HTML
Abstract
Congenital myasthenic syndromes comprise clinically and genetically heterogeneous disorders resulting from presynaptic, synaptic, or postsynaptic defects. Mutations in the COLQ gene result in acetylcholinesterase deficiency and cause a rare, autosomal recessive synaptic form of congenital myasthenic syndrome, with variable age of onset and clinical severity. We present four unrelated patients with a homozygous W148X mutation in the COLQ gene. Signs began at birth in all, but subsequent severity ranged from independent ambulation to wheelchair use during childhood. Treatment was partly effective; one patient was asymptomatic with 3,4-diaminopyridine treatment. These cases illustrate the clinical features and treatment results associated with this particular genotype, which appears to be relatively frequent among Turkish patients with congenital myasthenic syndrome.Copyright © 2012 Elsevier Inc. All rights reserved.
Related Compounds
Related Articles:
2015-11-15
[Food Chem. 187 , 159-65, (2015)]
Ectopic uterine tissue as a chronic pain generator.
2012-12-06
[Neuroscience 225 , 269-82, (2012)]
3-D-QSAR and docking studies on the neuronal choline transporter.
2010-08-15
[Bioorg. Med. Chem. Lett. 20 , 4870-7, (2010)]
Acute and chronic effects of botulinum neurotoxin a on the mammalian neuromuscular junction.
2014-08-01
[Muscle Nerve 50(2) , 206-15, (2014)]
Orphan drugs. BioMarin Europe replies.
2010-01-01
[BMJ 341 , c7006, (2010)]